Showing results (171-180 of 194) with videos related to
Sort By:
Pageof 20
Dementia and Geriatric Cognitive Disorders|January 24, 2004
Transcobalamin polymorphism and serum holo-transcobalamin in relation to Alzheimer's diseaseAndrew McCaddon, Kaj Blennow, Peter Hudson, et al.Antimicrobial Agents and Chemotherapy|January 24, 2019
Software for Dosage Individualization of Voriconazole: a Prospective Clinical StudyWilliam Hope, Gary Johnstone, Silvia Cicconi, et al.The Journal of Investigative Dermatology|July 22, 2018
A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for PsoriasisAmy C Foulkes, David S Watson, Daniel F Carr, et al.Journal of Psychopharmacology (Oxford, England)|October 25, 2006
Clinical practice with anti-dementia drugs: a consensus statement from British Association for PsychopharmacologyAlistair Burns, John O'Brien, , et al.Antimicrobial Agents and Chemotherapy|May 11, 2016
Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous MeningitisSam Nightingale, Tran Thi Hong Chau, Martin Fisher, et al.The Journal of Antimicrobial Chemotherapy|August 23, 2014
CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populationsDaniel F Carr, Mas Chaponda, Elena M Cornejo Castro, et al.European Journal of Nutrition|December 5, 2022
The importance of vitamin B12 for individuals choosing plant-based dietsAli Niklewicz, A David Smith, Alison Smith, et al.The Journal of Investigative Dermatology|December 29, 2022
TNF-α‒Mediated Keratinocyte Expression and Release of Matrix Metalloproteinase 9: Putative Mechanism of Pathogenesis in Stevens‒Johnson Syndrome/Toxic Epidermal NecrolysisAnna Olsson-Brown, Vincent Yip, Emeka D Ogiji, et al.International Journal of Neonatal Screening|September 23, 2024
Consistency in the Assessment of Dried Blood Spot Specimen Size and Quality in U.K. Newborn Screening LaboratoriesStuart J Moat, James R Bonham, Christine Cavanagh, et al.Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.Pageof 20